Exane BNP Paribas downgraded Nestle to Underperform from Neutral with a CHF 96 price target. The firm changed ratings in the food space as part of its 2024 outlook. Staples valuations are “looking reasonable” but operationally “there is little to enthuse,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NSRGY:
- Codexis enters into purchase agreement with Nestle Health Science for CDX-7108
- Codexis enters into pruchase agreement with Nestle Health Science for CDX-7108
- Nestle price target lowered to CHF 110 from CHF 113 at Deutsche Bank
- Nestle assumed with Underperform from Hold at Jefferies
- Nestle price target lowered to CHF 125 from CHF 130 at JPMorgan